Cite
HARVARD Citation
van der Heijden, E. et al. (2020). Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial. Lancet. pp. e260-e269. [Online].